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MyD88-dependent IL-1 receptor signaling  
is essential for gouty inflammation stimulated 
by monosodium urate crystals
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Shizuo Akira,3 and Kenneth L. Rock1
1Department of Pathology and 2Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.  
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While	it	is	known	that	monosodium	urate	(MSU)	crystals	cause	the	disease	gout,	the	mechanism	by	which	
these	crystals	stimulate	this	inflammatory	condition	has	not	been	clear.	Here	we	find	that	the	Toll/IL-1R	
(TIR)	signal	transduction	adaptor	myeloid	differentiation	primary	response	protein	88	(MyD88)	is	required	
for	acute	gouty	inflammation.	In	contrast,	other	TIR	adaptor	molecules,	TIRAP/Mal,	TRIF,	and	TRAM,	
are	not	required	for	this	process.	The	MyD88-dependent	TLR1,	-2,	-4,	-6,	-7,	-9,	and	-11	and	IL-18	receptor	
(IL-18R)	are	not	essential	for	MSU-induced	inflammation.	Moreover,	MSU	does	not	stimulate	HEK	cells	
expressing	TLR1–11	to	activate	NF-kB.	In	contrast,	mice	deficient	in	the	MyD88-dependent	IL-1R	showed	
reduced	inflammatory	responses,	similar	to	those	observed	in	MyD88-deficient	mice.	Similarly,	mice	treat-
ed	with	IL-1	neutralizing	antibodies	also	showed	reduced	MSU-induced	inflammation,	demonstrating	that	
IL-1	production	and	IL-1R	activation	play	essential	roles	in	MSU-triggered	inflammation.	IL-1R	deficiency	
in	bone	marrow–derived	cells	did	not	affect	the	inflammatory	response;	however,	it	was	required	in	non–
bone	marrow–derived	cells.	These	results	indicate	that	IL-1	is	essential	for	the	MSU-induced	inflammatory	
response	and	that	the	requirement	of	MyD88	in	this	process	is	primarily	through	its	function	as	an	adaptor	
molecule	in	the	IL-1R	signaling	pathway.
Introduction
Gout is one of the oldest recorded afflictions of humans. It occurs 
in individuals with hyperuricemia when monosodium urate (MSU) 
crystals precipitate in tissues and stimulate acute inflammation (1). 
Although uric acid was identified in gout in the late 1700s (2) and 
shown to be the causative agent of this disease in 1899 (3), we have 
not known exactly how MSU crystals trigger acute inflammation. 
Several different mechanisms have been suggested as underlying 
this inflammatory response. It has been proposed that MSU crystals 
induce inflammation by mechanically disrupting phagolysosomes 
and killing neutrophils, with the attendant release of destructive 
enzymes (4). Alternatively, it has been suggested that extracellular 
MSU crystals activate complement (5–9) and other extracellular 
enzymes such as bradykinin and kallikrein and thereby generate 
proinflammatory mediators (10). Yet another potential mechanism 
is that phagocytosis of MSU crystals may stimulate the production 
of eicosanoids and reactive oxygen species (11–13) as well as proin-
flammatory cytokines (e.g., TNF-a [ref. 14], IL-1b [ref. 15–17], and 
IL-6 [ref. 18]). In addition, increased levels of chemokine mono-
cyte chemoattractant protein–1 (MCP-1) (19) and the chemotactic 
factors for neutrophils, such as the C-X-C chemokines IL-8 (in 
humans) (20), keratinocyte-derived chemokine (KC) and macro-
phage inflammatory protein–2 (MIP-2) (in rodents) (17, 21), and 
myeloid-related proteins S100A8/A9 (22) and S100A12 (23), have 
also been detected in synovial fluid of patients with acute gout or 
in murine gout models. The exact contributions of these different 
mechanisms to gouty inflammation and the mechanisms by which 
cellular responses were triggered have not been fully understood.
Recently, it was also found that urate release from injured cells 
provides an adjuvant signal that alerts the immune system to dan-
ger (24). Adjuvants were originally discovered in the early 1920s 
as immunostimulatory molecules (25, 26) and later shown to be 
essential components for successful immunization. Until recently, 
most known adjuvants were molecules of microbial origin whose 
chemically distinct structures were recognized by receptors on sen-
tinel cells of the immune system, such as macrophages and dendrit-
ic cells (27, 28). As a consequence of this recognition, the immune 
cells are stimulated to begin to combat the microbe directly and 
also to recruit further immune responses. It is believed that this 
recognition system evolved to allow the immune system to identify 
and selectively respond to infections (27). Urate represented a new 
class of adjuvant molecules being produced by the host itself and 
of a distinct chemical structure. This helped to explain how the 
immune system can respond to stimuli such as tumors and trans-
plants that lack microbial components (29). It was postulated that 
this role of MSU in triggering the innate immune system might 
underlie the pathogenesis of gout: crystals deposit in tissues of 
hyperuricemic patients and signal “danger” (24).
While we don’t fully understand how MSU stimulates its biolog-
ical effects, the mechanisms underlying activity of microbial adju-
vants are much better understood. These molecules are recognized 
by pattern recognition receptors such as TLRs (28). Once stimu-
lated, the TLRs associate with intracellular adaptor molecules 
(Toll/IL-1R [TIR] adaptors) to initiate a signaling cascade that 
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activates proinflammatory transcription factors such as NF-kB 
and IFN regulatory factors (IRFs) (30). Given that microbial mol-
ecules and MSU both have adjuvant and proinflammatory proper-
ties, we hypothesized that these 2 classes of immunologically active 
molecules might signal through similar pathways. This study was 
initiated to test this hypothesis.
Results
The role of TLRs in MSU-stimulated acute inflammation. The hallmark 
of the response to MSU in gout is acute inflammation with an 
infiltration of neutrophils at the site of crystal deposition in vivo. 
Although in gout MSU crystals most typically form in joints, 
causing arthritis, deposition elsewhere either pathologically or 
by experimental injection induces acute inflammation (31–33). 
To study the acute inflammatory response to MSU crystals, we 
injected them into the peritoneal cavity in mice. Six hours after 
injection, we analyzed the exudate cells in the peritoneum. There 
was a marked influx of cells that express the neutrophil markers 
Ly-6G and 7/4 into this site (Figure 1A), and the number of neu-
trophils further increased at 16 hours after MSU injection (Figure 
1B). Using this model, we investigated how MSU crystals stimu-
lated acute inflammation.
One of the principal sets of receptors for microbial molecules 
that stimulate inflammation and adjuvant effects are the TLRs. To 
test the hypothesis that MSU signals through a mechanism similar 
to that of microbial proinflammatory molecules, we first exam-
ined whether MSU stimulated inflammation in mice deficient in 
various TLRs. MSU crystals were injected into the peritoneum of 
all of the available TLR-deficient mice, and the acute inflammato-
ry response was evaluated by quantifying the influx of neutrophils. 
The MSU-induced inflammation was not reduced in TLR1, -2, -3, 
-4, -6, -7, -9, and -11–deficient mice (Figure 2). Statistical analysis 
of the results of 3 independent experiments using 6–9 total mice 
(except for n = 3 for TLR7–/– mice) showed no significant reduction 
in neutrophil infiltration in TLR-deficient animals compared with 
the WT animals; in fact, we actually observed significant increases 
in neutrophil influx in mice deficient of TLR1, -3, -4, -6, and -9. 
Therefore, none of these TLRs are required for responses to MSU 
and, if TLRs play any role, it is so minor as to be undetectable with 
the numbers of mice that we analyzed. Our results are different 
from what was reported recently by Liu-Bryan et al. (34): that 
MSU-stimulated neutrophil influx in a subcutaneous air pouch 
model is reduced in TLR2–/– and TLR4–/– mice. To further exam-
ine whether TLR2 and TLR4 are involved in the inflammatory 
response stimulated by MSU, we injected MSU i.p. into TLR2/4 
double-deficient mice and found that neutrophil infiltration into 
the peritoneum was not affected compared with that in WT mice 
(Figure 2I), demonstrating that TLR2 and TLR4 are not essential 
for MSU-induced inflammation. The TLR10 gene in mice is not 
functional due to a retroviral insertion and therefore cannot be 
participating in the MSU response (35). Mice deficient for TLR5 
and TLR8 are not yet available, so these experiments by themselves 
do not rule out a role for these 2 TLRs.
To confirm the above results and also rule out the possibility 
that MSU crystals stimulate TLR5, TLR8, or more than one TLR, 
we performed a second set of gain-of-function experiments. Stim-
ulation of TLRs leads to the activation of the transcription fac-
tor NF-kB through the myeloid differentiation primary response 
protein 88–dependent (MyD88-dependent) pathway. According-
ly, activation of a NF-kB luciferase construct in TLR-expressing 
HEK cells has been used as a sensitive assay for TLR function (36). 
Therefore, we used this experimental system to determine whether 
MSU crystals would stimulate HEK cells expressing various endog-
enous or transfected TLRs to activate a NF-kB–luciferase reporter 
gene. HEK cells naturally express TLR1, TLR5, and TLR6 (37). 
When these cells were transfected with TLR2, -3, -7, -8, or -9 or 
TLR4+MD2, they responded to the appropriate TLR ligands and 
activated the NF-kB reporter gene (Figure 3). In contrast, HEK cells 
expressing TLR1–11 failed to respond to MSU crystals (Figure 3). 
Although we did not have natural ligands for TLR10 and TLR11, 
we confirmed that these cells could activate NF-kB in response to 
IL-1b. Thus, MSU does not stimulate HEK cells through any of the 
11 TLRs. Taken together, the results of the loss-of-function and 
gain-of-function experiments suggest that MSU does not stimu-
late the inflammatory response through any of the known TLRs. 
These data also indicate that our MSU crystal preparations lacked 
contaminating TLR agonists.
The role of TIR adaptor proteins in MSU-stimulated inflammation. 
TLRs signal through intracellular TIR adaptor molecules (30). In a 
related set of experiments, we examined whether MSU stimulated 
Figure 1
MSU induces peritonitis in mice. (A and B) C57BL/6 mice 
were challenged i.p. with 3 mg of MSU crystals. Mice chal-
lenged with PBS served as negative controls. Peritoneal 
cells were stained for Ly-6G and 7/4 expression and ana-
lyzed by flow cytometry. (A) Representative dot plots of 
Ly-6G and 7/4 expression on peritoneal cells in animals 
injected 6 hours earlier with PBS or MSU. The Ly-6G+7/4+ 
gate represents neutrophils. (B) At indicated time points, 
neutrophil numbers in PECs were determined by multiply-
ing the total cell numbers by the percentage of Ly-6G+7/4+ 
cells (n = 3). (C) C57BL/6 mice were challenged i.p. with 
1.5 mg of MSU crystals, 1.5 mg of uricase-digested MSU 
(MSU+Uox), or borate buffer. At 16 hours after challenge, 
neutrophil numbers in the PECs were determined (n = 3). 
Data shown are representative of 3 or more experiments.
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inflammation in mice deficient for each of the 4 known TIR adap-
tors: MyD88, TIR domain–containing adaptor protein/MyD88 
adaptor–like protein (TIRAP/Mal), TIR domain–containing adap-
tor–inducing IFN-b (TRIF), and TRIF-related adaptor molecule 
(TRAM). There was no reduction in inflammation in mice defi-
cient for TRAM (Figure 4A), TIRAP/Mal (Figure 4B), or TRIF (Fig-
ure 4C). Surprisingly however, the acute inflammatory response in 
MyD88-deficient mice was reduced by 92% (P = 0.001) at 6 hours 
and by 93% (P = 0.00013) at 16 hours (Figure 4D). We also assayed 
the peritoneal lavage fluid for the presence of KC and MIP-2, 
which are 2 chemokines that attract neutrophils. MSU induced 
high levels of KC and MIP-2 in the peritoneal cavity of WT mice. 
Consistent with the reduced neutrophil infiltration, in MyD88-
deficient mice the production of KC and MIP-2 was reduced by 
90% and 77%, respectively (Figure 4, E and F).
Since MSU crystals failed to stimulate through any of the TLRs, 
it seemed unlikely that the MyD88-dependent inflammation was 
due to any microbial contaminants in our crystals preparations. 
However, to rule out this possibility, we treated the MSU crystals 
with uricase, a highly specific enzyme that oxidizes uric acid; this 
treatment eliminates MSU but would have no effect on a microbial 
contaminant. Uricase treatment of MSU crystals destroyed their 
ability to induce acute inflammation (Figure 1C). Therefore, these 
results demonstrate that MSU crystals stimulate acute inflamma-
tion in vivo through a MyD88-dependent pathway and one that 
does not appear to be utilizing TLRs.
Role of IL-1 and IL-18 receptors in MSU-stimulated inflammation. The 
other receptors that are well known to signal through MyD88 are 
the IL-1 receptor (IL-1R) and IL-18R. Given the key role of MyD88 
in gouty inflammation, we sought to evaluate the role of these 
2 cytokine receptors in this response. MSU crystals were inject-
ed into the peritoneal cavity of IL-1R or IL-18R–deficient mice, 
and the acute inflammatory response was evaluated. There was a 
reduction of 85% in the neutrophil response in IL-1R mutant mice 
at both 6 hours and 16 hours (Figure 5A). Similarly, the levels of 
neutrophil chemoattractants KC and MIP-2 were also reduced in 
IL-1R mutant mice (Figure 5, B and C). In contrast, the inflamma-
tory response was not reduced in IL-18R–deficient mice (Figure 
5D). These results demonstrated that the IL-1R plays an impor-
tant role in the acute inflammatory response to MSU.
We next sought to determine precisely how the IL-1R was par-
ticipating in the inflammatory response to MSU. The identity of 
the cellular receptor(s) that are stimulated by MSU crystals is not 
clear. Our findings raised the possibility that the IL-1R might be 
the cellular receptor for MSU. To evaluate this possibility, we tested 
the ability of MSU crystals to stimulate leukocytes from WT and 
IL-1R–deficient mice. We found that when WT peritoneal resident 
cells (primarily macrophages) were stimulated ex vivo with MSU, 
Figure 2
MSU-induced inflammation does not require TLR1, -2, -3, -4, -6, -7, -9, and -11. C57BL/6 mice and mice deficient for TLR1 (A), TLR2 (B), TLR3 
(C), TLR4 (D), TLR6 (E), TLR7 (F), TLR9 (G), TLR11 (H), or TLR2/4 (I) were challenged i.p. with 3 mg of MSU crystals (in PBS). C57BL/6 mice 
challenged with PBS served as negative controls. At 16 hours after challenge, neutrophil numbers in PECs were determined. Data (mean ± SEM) 
shown in A–E and G–I were combined from 3 independent experiments, and n’s reported represent the combined numbers of animals for each 
group. Data shown in F are from a single experiment due to the limited availability of animals (n = 3).
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they produced as expected the proinflammatory cytokine IL-1b 
(Figure 6A) as well as TNF-a (Figure 6B), albeit at lower levels. 
Importantly, these responses were not reduced in peritoneal cells 
from IL-1R–deficient mice. Therefore, the IL-1R is not required for 
these cells to respond to MSU crystals.
Another obvious possibility was that the IL-1R was needed to 
respond to IL-1 that was produced in response to MSU. To test 
this possibility, we injected MSU crystals into mice that were 
treated with neutralizing antibodies to IL-1a and IL-1b. The 
anti–IL-1 antibodies caused a significant reduction in the inflam-
matory response (Figure 7A). This reduction in acute inflamma-
tion was not as great as that observed in IL-1R–deficient mice, 
presumably because the antibody treatment was not neutralizing 
IL-1 completely. We conclude that MSU crystals stimulate the 
production of IL-1 that then binds the IL-1R and signals through 
MyD88 to cause inflammation.
Given the key role of the IL-1R–MyD88 pathway in the MSU 
response, we further examined the generation of IL-1b in this 
model. We measured the levels of IL-1b in the peritoneal fluids 
and found that MSU stimulated the production of IL-1b in WT 
mice, but IL-1b production was significantly reduced in both 
MyD88-deficient and IL-1R–deficient mice (Figure 7B). These 
results indicate that the IL-1R–MyD88 pathway plays a role in the 
optimal production of IL-1b in vivo, possibly because this path-
way is required for the efficient recruitment of neutrophils and 
monocytes, which then can be stimulated by MSU to produce IL-1b. 
Alternatively, the IL-1R–MyD88 pathway might be required for 
optimal IL-1b production via autocrine or paracrine 
mechanisms that amplify the response.
Analysis of where the IL-1R–MyD88 pathway functions in 
vivo. The IL-1R is broadly expressed, and many cell types 
can produce IL-1. To further understand where the 
IL-1R–MyD88 pathway was needed in MSU responses, 
we analyzed mice chimeric for the IL-1R or MyD88. 
WT mice that were reconstituted with IL-1R–deficient 
bone marrow (IL-1R–/–→WT) showed no significant 
reduction in inflammatory responses to MSU crystals 
in 7 of 8 experiments that we performed (Figure 8A); 
in one experiment, the chimeric mice showed a signifi-
cantly reduced neutrophil recruitment. Overall, there 
was no significant difference in inflammation between 
the IL-1R (IL-1R–/–→WT) and WT (WT→WT) chimeric 
mice. Therefore, the IL-1R is not required on leukocytes 
for this response. This result was consistent with our 
observation that MSU stimulated IL-1b production in 
IL-1R–deficient peritoneal cells (Figure 6A). In contrast, 
IL-1R–deficient mice reconstituted with WT bone mar-
row (WT→IL-1R–/–) had markedly reduced inflamma-
tory responses to MSU crystals (Figure 8B). Therefore, 
the IL-1R is required on radioresistant (non–bone marrow–derived) 
host cells to respond to IL-1. Consistent with this result, our pre-
liminary data indicate that MSU-stimulated inflammation was 
reduced in MyD88-deficient mice reconstituted with WT bone 
marrow (data not shown). In the chimeric mice whose bone mar-
row–derived but not other cells lacked MyD88 (MyD88–/–→WT), 
MSU-stimulated inflammatory response was significantly reduced 
in only 1 of 8 experiments. These experiments overall showed no 
significant reduction in inflammation in MyD88–/–→WT mice (Fig-
ure 8A), indicating that MyD88 expression in bone marrow–derived 
cells is not essential. Therefore, MyD88 is required in the radioresis-
tant host cells, presumably for its role in transducing IL-1R signals.
Discussion
One of the central observations in this report is that MSU crystals do 
not stimulate acute inflammation in mice that genetically lack the 
TIR adaptor protein MyD88. Mice lacking MyD88 showed reduced 
production of the proinflammatory cytokines IL-1b, KC, and MIP-2 
and showed reduced neutrophil accumulation in response to MSU 
in vivo. Therefore, our data identify MyD88 as a key signaling mol-
ecule in MSU-stimulated inflammation. In contrast, MSU did 
stimulate inflammation in mice that genetically lacked TIRAP/Mal, 
TRIF, or TRAM. Therefore, among the TIR adaptors, MyD88 plays 
a unique role in MSU-stimulated inflammation.
Another major finding is that MyD88 is primarily required for 
transducing signals downstream of the IL-1R, while most, and 
probably all, TLRs and the IL-18R are not essential for the inflam-
Figure 3
MSU does not stimulate transfected TLRs in vitro. HEK 
cells were prepared as described in Methods. The fol-
lowing TLR ligands were added to the cells: Malp2 
(100 ng/ml), Poly(I:C) (200 mg/ml), LPS (1 ng/ml), R-848 
(1 mg/ml), and CpG (5 mg/ml). TLR10 and TLR11 ligands 
were unavailable for the test. The readout is the fold 
increase of firefly luciferase/Renilla luciferase ratio over 
the unstimulated control. Data shown are representative 
of 2 or more experiments.
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matory response to MSU. Our results clearly demonstrate that 
IL-1 is a major proinflammatory cytokine mediating the neutro-
philic gouty inflammation to MSU in vivo. While IL-1 is known 
to be a proinflammatory cytokine and produced in response to 
MSU, its key role in gouty inflammation in vivo has not, to our 
knowledge, previously been shown. Experiments with chimeric 
mice further demonstrated that this IL-1R–MyD88–dependent 
proinflammatory pathway is operating mainly in non–bone mar-
row–derived cellular elements.
Whether MSU stimulates a specific cell surface receptor(s) on tis-
sue-resident or -lining cells to produce proinflammatory cytokines 
and initiate the inflammatory response is unclear. Our finding 
that MSU-stimulated inflammation requires MyD88 raised the 
possibility that TLR signaling played some role in mediating the 
inflammatory response. However, MSU-stimulated inflammation 
was not affected in the mice genetically deficient in TLR1, -2, -4, 
-2/4, -6, -7, -9, or -11, ruling out the possibility that any of these 
MyD88-dependent TLRs is essential for the response. TLR3, which 
Figure 4
MyD88, but not TRAM, Mal, or TRIF, is required for MSU-induced KC and MIP-2 production and neutrophil infiltration in the peritoneal cavity. 
(A–C) B6129 mice and mice deficient for TRAM (A), Mal (B), or TRIF (C) were challenged i.p. with 3 mg of MSU crystals (in PBS). B6129 mice 
challenged with PBS served as negative controls. At 16 hours after MSU challenge, neutrophil numbers in the PECs were determined (n = 3). 
(D–F) C57BL/6 and MyD88–/– mice were challenged i.p. with 3 mg of MSU crystals (in PBS). C57BL/6 mice challenged with PBS served as 
negative controls. (D) At the indicated time points, neutrophil numbers in the PECs were determined (n = 3 for 6 hours and n = 4 for 16 hours). 
At 6 hours after MSU challenge, KC (E) and MIP-2 (F) concentrations in the peritoneal lavage fluids were determined by ELISA (n = 3). Data 
shown are representative of 3 or more experiments. *P < 0.01 versus control (C57BL/6) in D–F.
Figure 5
MSU-induced inflammation is IL-1R 
dependent and IL-18R independent. 
C57BL/6 mice and mice deficient for 
IL-1R (A–C) or IL-18R (D) were chal-
lenged i.p. with 3 mg of MSU crystals 
(in PBS). C57BL/6 mice challenged 
with PBS served as negative controls. 
(A) At indicated time points, neutrophil 
numbers in the PECs were determined 
(n = 4). At 6 hours after MSU challenge, 
KC (B) and MIP-2 (C) concentrations 
in the peritoneal lavage fluids were 
determined by ELISA (n = 4). (D) At 16 
hours after MSU challenge, neutrophil 
numbers in the PECs were determined 
(n = 4). Data shown in A–C are rep-
resentative of 3 or more experiments. 
Data shown in D are representative of 
2 experiments. *P < 0.01 versus con-
trol (C57BL/6) in A and B.
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signals through TRIF instead of MyD88, was also not involved. 
Furthermore, the finding that MSU fails to stimulate HEK cells 
expressing TLR1–11 also makes it unlikely that MSU directly stim-
ulates any TLRs. While this report was in preparation, Liu-Bryan 
et al. reported that MSU-stimulated inflammatory response was 
attenuated in MyD88–/– mice; however, in contrast to our results, 
they found that the inflammation was also reduced in mice lack-
ing the MyD88-associated receptors TLR2 and TLR4 (34). The 
discrepancies between their and our results may be due to the 
different in vivo models employed; Liu-Bryan et al. injected MSU 
into subcutaneous air pouches, while we injected MSU into the 
peritoneal cavity; perhaps cells in different tissues respond to MSU 
stimulation through different mechanisms. Alternatively, perhaps 
Liu-Bryan’s crystal preparations differ in other ways that allowed 
them to interact with TLRs.
Although we can find no evidence that in vivo MSU is working 
through TLRs, it remains formally possible that MSU-stimu-
lated inflammation may involve several TLRs that are activated 
redundantly or some TLR(s) that we have not examined in vivo, 
e.g., TLR5 or TLR8. This possibility is made unlikely by our find-
ing that MSU does not stimulate HEK cells expressing TLR1–11; 
however, we cannot exclude the possibility that HEK cells lack 
the expression of some molecules that are required to form com-
plexes with certain TLRs, which may mediate the response to 
MSU stimulation. This possibility could explain the different 
observations made by us and by Liu-Bryan et al., who reported 
that TLR2 expression in chondrocytes plays a role in MSU-
induced nitric oxide production (38). However, we do not favor 
the possibility that TLR2 plays an essential role in vivo, because 
in our system, mice lacking TLR2, or both TLR2 and TLR4 
together, show an undiminished inflammatory response to 
MSU crystals. Interestingly, in mice lacking TLR4, we observed a 
significant increase in neutrophil infiltration. It is possible that 
this is because TLR4 mediates some antiinflammatory function, 
such as TGF-b1 production from differentiated macrophages, 
during MSU-induced inflammation (34, 39). However, the basis 
for the observation in our studies was not elucidated, and other 
potential mechanisms are possible.
We also show that MSU does not signal directly through the 
IL-1R or IL-18R, both of which are MyD88-dependent receptors. 
Other cell surface receptors that have been proposed to respond to 
MSU include the CD16 and complement receptors on neutrophils 
(40) and membrane integrins (GPIIb/IIIa) on platelets (41). Howev-
er, these in vitro studies do not provide information as to whether 
these receptors are essential for MSU-stimulated inflammation in 
vivo. In fact, we have been able to stimulate human monocytic leu-
kemia THP-1 cells, which lack the expression of CD16 (42), with 
MSU to produce IL-1b (unpublished observations). Furthermore, 
MSU-stimulated dendritic cell activation cannot be blocked by an 
anti-CD16 antibody (unpublished observations).
Instead, our data indicate that MSU stimulates cells to produce 
IL-1 (through as-yet-unknown mechanism[s]/receptor[s]). The 
IL-1 that is produced is essential for gouty inflammation, as neu-
tralizing it with antibodies suppressed the inflammatory response. 
Figure 6
IL-1R is not the receptor for MSU stimulation. Peritoneal resident cells 
from C57BL/6 and IL-1R–/– mice were harvested and stimulated with or 
without MSU crystals as described in Methods. At 16 hours after MSU 
stimulation, IL-1b (A) and TNF-a (B) concentrations in the culture flu-
ids were determined by ELISA (n = 2). Data shown are representative 
of 3 or more experiments.
Figure 7
The role of IL-1 in MSU-induced inflammation. (A) C57BL/6 mice were 
administered i.v. with anti–IL-1 antibodies or PBS (vehicle). Thirty min-
utes later, the treated mice and IL-1R–/– mice were challenged i.p. with 
MSU crystals. C57BL/6 mice challenged with PBS served as negative 
controls. At 6 hours after MSU challenge, neutrophil numbers in the 
PECs were determined (n = 4). *P < 0.01 versus control (vehicle). (B) 
C57BL/6, MyD88–/–, and IL-1R–/– mice were challenged i.p. with 3 mg 
of MSU crystals (in PBS). C57BL/6 mice challenged with PBS served 
as negative controls. At 6 hours after MSU challenge, IL-1b concentra-
tion in the peritoneal lavage fluids were determined by ELISA (n = 5). 
Data shown are representative of 2 experiments in A and 3 experi-
ments in B. *P < 0.01 versus control (C57BL/6).
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Moreover, mice deficient in the IL-1R showed markedly reduced 
inflammatory responses. Although the IL-1R is not involved in 
MSU triggering of cells to initially produce IL-1, our data indicate 
that the resulting IL-1 stimulation of the IL-1R amplifies the pro-
duction of proinflammatory cytokines through a MyD88-depen-
dent pathway and is a major step in controlling the development 
of full-blown inflammation. While it has been recognized that 
MSU stimulates cells to produce IL-1 (15–17) along with many 
other cytokines, the central role of IL-1 in gouty inflammation has 
not been previously shown. While this report was under review, 
Martinon and colleagues reported that MSU crystals engage the 
caspase-1–activating NALP3 inflammasome, resulting in the pro-
duction of active IL-1b and IL-18 (43). Their studies provide the 
mechanistic evidence of IL-1 production in response to MSU stim-
ulation; furthermore, they also show that MSU-induced inflam-
mation is impaired in mice deficient in inflammasome or IL-1R, 
consistent with our findings that IL-1 production and IL-1R sig-
naling play essential roles in MSU-induced inflammation.
Chimeric mice whose radioresistant cells lack the IL-1R or 
MyD88 showed markedly reduced inflammatory responses simi-
lar to those in IL-1R–/– or MyD88–/– mice, indicating that expres-
sion of IL-1R or MyD88 in bone marrow–derived cells alone is 
not sufficient for MSU to stimulate inflammation. In contrast, 
MSU-stimulated inflammatory responses were not reduced in 
chimeric mice lacking IL-1R or MyD88 only on bone marrow ele-
ments. Therefore, the IL-1R–MyD88–dependent step is mainly 
operating in non–bone marrow–derived cells. We speculate that 
these non-hematopoietic cells include vascular endothelium, 
as IL-1 activates endothelial cells and induces the expression 
of the leukocyte adhesion molecule E-selectin (44). Both IL-1 
and TNF-a are major proinflammatory cytokines that activate 
endothelial cells (44). When peritoneal resident cells were stimu-
lated with MSU ex vivo, more (>3-fold) IL-1b than TNF-a was 
produced, and when mice were challenged with MSU in vivo, the 
level of TNF-a in the lavage fluid at 6 hours was undetectable, 
presumably because it was produced at levels below the limit 
of detection in our assay (data not shown). Since much more 
IL-1 than TNF-a was produced in response to MSU, IL-1 may 
be responsible for vascular endothelial activation. Also consis-
tent with this speculation is that endothelial cells are primar-
ily responsible for producing neutrophil-attracting chemokine 
KC (45), and the MSU-stimulated production of this chemo-
kine was markedly reduced in IL-1R–/– and MyD88–/– mice. KC 
is thought to be important to the MSU-induced acute inflam-
matory responses because the neutrophil influx is inhibited in 
mice lacking the receptor for KC (CXCR2) (46). In the absence of 
endothelial activation and high-level expression of selectins and 
KC, neutrophil adhesion to the endothelium and subsequent 
extravasation would be markedly reduced. IL-1 will also affect 
other non-hematopoietic cells, and these may also contribute to 
the inflammatory process.
Our data lead to the model shown in Figure 9. In vivo, nucle-
ation of MSU converts the nonphlogistic form of uric acid to 
MSU crystals. This chemical phase change allows the MSU to 
then interact with cells in ways that stimulate the production of 
IL-1 and other cytokines. The IL-1 that is produced then stimu-
lates the IL-1R on non–bone marrow–derived cells, resulting 
Figure 9
Proposed mechanism for MSU-induced inflammation. When uric acid 
nucleates to form MSU crystals, tissue resident cells are stimulated 
to produce IL-1 and other cytokines. The IL-1 that is produced then 
stimulates the IL-1R on non–bone marrow–derived cells, resulting in a 
MyD88-dependent amplification of the proinflammatory response.
Figure 8
Functions of IL-1R and MyD88 in bone marrow– versus non–bone 
marrow–derived cells mediating MSU-stimulated inflammation. Bone 
marrow chimeras were generated as described in Methods. (A) 
C57BL/6 (WT) mice served as hosts, and B6.SJL (WT), MyD88–/–, 
or IL-1R–/– mice served as bone marrow donors. (B) C57BL/6 (WT) 
and IL-1R–/– mice served as hosts, and B6.SJL (WT) mice served as 
bone marrow donors. (A and B) After bone marrow reconstitution, chi-
meric mice were challenged i.p. with 3 mg of MSU crystals (in PBS). 
C57BL/6 mice challenged with PBS served as negative controls. At 
16 hours after MSU challenge, neutrophil numbers in the PECs were 
determined (n = 3). Data shown in A are representative of 8 experi-
ments; data shown in B are representative of 3 experiments. *P < 0.01 
versus control (WT→WT).
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in a MyD88-dependent amplification of the proinflammatory 
response (including the production of more IL-1 and chemokines 
that attract neutrophils [e.g., KC and MIP-2]) and the recruitment 
of neutrophils. Together, these findings provide important new 
insights into gout, a disease recognized since the time of antiq-
uity but still incompletely understood. The data clearly demon-
strate that a cellular adaptor protein, MyD88, is necessary for the 
MSU-stimulated inflammatory response. In addition, our find-
ings demonstrate a central role for IL-1 signaling through the 
IL-1R–MyD88 pathway in gouty inflammation.
Methods
Animals and cell lines. C57BL/6, IL-1R–/–, and IL-18R–/– mice (8–12 weeks 
old) were purchased from the Jackson Laboratory. B6 × 129 F1 (B6129) 
mice (8–12 weeks old) were purchased from Taconic. MyD88–/– (47), 
TIRAP/Mal–/– (48), TRIF–/– (49), TRAM–/– (50), TLR1–/– (51), TLR2–/– (52), 
TLR3–/–, TLR4–/– (53), TLR6–/– (54), TLR7–/– (55), and TLR9–/– (56) mice 
were generated at the Department of Host Defense, Osaka University, 
Osaka, Japan. TLR11–/– (57) mice were kindly provided by Sanker Ghosh 
(Yale University, New Haven, Connecticut, USA). TLR2/4–/– mice were 
generated by crossing TLR2–/– with TLR4–/– mice. All animal studies were 
approved by the Institute Animal Care and Use Committee of the Uni-
versity of Massachusetts Medical School, and all mice were kept in the 
University of Massachusetts Medical School animal facilities. HEK 293 
cells were maintained in hybridoma culture medium (HCM) consisting 
of RPMI 1640 plus 10% FBS, 2 mM l-glutamine, 10 mM HEPES, penicil-
lin/streptomycin, and 50 mM 2-mercaptoethanol.
Reagents. Poly(I:C) was purchased from Amersham Biosciences. LPS and 
uric acid were purchased from Sigma-Aldrich. CpG (ODN1826) was pur-
chased from Coley. R-848 was purchased from GLSynthesis Inc. Malp2 was 
purchased from EMC Microcollections. Uricase (Elitek) was purchased 
from Sanofi-Aventis. MSU crystals were prepared by first dissolving uric 
acid (5 mg/ml) in 0.1 M borate buffer (pH 8.5), and, after passing through 
a 0.45-mm filter, the supersaturated uric acid solution was left at room tem-
perature for 48 hours. The large crystals formed during the first 48 hours 
were removed by centrifugation, and the supernatant uric acid solution 
was incubated at room temperature for 5 more days to allow the formation 
of fine crystals, which were harvested by centrifugation. After 2 washes 
with absolute alcohol and 1 wash with acetone, the crystals were allowed 
to air dry. Crystal size varied between 3 mm and 50 mm in length, with 
48% of crystals less than 10 mm in length and a mean ± SD crystal size of 
11.69 ± 6.6 mm. All reagents were prepared under pyrogen-free conditions.
Luciferase reporter assay. HEK 293 cells were grown to about 80% conflu-
ence in a 96-well plate and transfected with 80 ng NF-kB luciferase report 
gene and 40 ng of control Renilla luciferase reporter gene, along with 3 mg 
of various constructs expressing mouse TLR2, -3, -4, -7, -9, or  -11 or human 
TLR8 or TLR10 (all in pCDNA3 vector) (58, 59). Sixteen hours later, cells 
were washed once with fresh medium and added with 1 ng/ml of recombi-
nant human IL-1b or TNF-a (R&D Systems), 300 mg/ml of MSU crystals, 
or TLR ligands, as indicated in the figure legends, in a total volume of 100 
ml per well. Luminescence was read 6 hours later using the Dual-Luciferase 
Reporter Assay System (Promega) and a fluorometer.
Generation of bone marrow chimeras. C57BL/6, MyD88–/–, and IL-1R–/– mice 
were lethally irradiated using 11 Gy. Bone marrow was prepared from the 
femurs and tibias of B6.SJL-Ptprca/BoAiTac (B6.SJL, CD45.1), MyD88–/–, 
or IL-1R–/– donor mice and depleted of T cells using a mAb against Thy1, 
M5/149 (ATCC), and complement (Pel-Freez Biologicals). The irradiated 
mice were reconstituted i.v. with 2.5 × 106 of different T cell–depleted bone 
marrow cells, as indicated. The mice were then housed for 3–4 months to 
allow for the turnover and reconstitution of bone marrow–derived cells. 
The reconstitution of the chimeras was confirmed by staining blood leuko-
cytes with anti-CD45.1 and anti-CD45.2 antibodies (BD Biosciences) and 
flow cytometric analysis.
MSU-induced inflammation in vivo. Mice were injected i.p. with 3 mg MSU 
crystals in 0.1 ml PBS, 1.5 mg MSU in 0.3 ml borate buffer (0.1 M, pH 8.5), 
or 1.5 mg uricase-digested MSU (in 0.3 ml borate buffer). Equal volumes 
of PBS or borate buffer were injected into 2 mice and served as negative 
controls. The TLR-deficient mice were originally on the 129 background, 
and some were not yet fully backcrossed onto the C57BL/6 background. 
In preliminary experiments, we found that the response of C57BL/6 and 
B6129 F1 mice to MSU is not different (data not shown) and therefore 
used C57BL/6 mice for a comparison. To analyze the involvement of IL-1 
in MSU-induced inflammation, mice were administered i.v. with 10 mg 
each of neutralizing rabbit polyclonal anti–IL-1a and anti–IL-1b anti-
bodies (in 0.3 ml PBS) (Abcam) or 0.3 ml PBS 30 minutes before MSU 
injection. At different time points, animals were euthanized by CO2 expo-
sure, and their peritoneal cavities were washed with 6 ml HCM containing 
3 mM EDTA and 10 U/ml heparin. Total numbers of peritoneal exudate 
cells (PECs) were counted by a hematocytometer, and lavage fluids were 
centrifuged at 450 g for 10 minutes. Supernatants were stored at –20°C 
before analysis for cytokines, and cells were resuspended in HCM and sub-
jected to staining and flow cytometric analysis. Neutrophil numbers in 
the PECs were determined by multiplying the total cell numbers by the 
percentage of Ly-6G+7/4+ cells.
Flow cytometric analysis. PECs (1 × 106) were incubated with mAb 2.4G2 
for 30 minutes to block FcgRIIB/III receptors and stained with mAbs 
Ly-6G–FITC (BD Biosciences) and 7/4-biotin (AbD Serotec) for 30 min-
utes at 4°C. The cells were further incubated with streptavidin-APC. Fol-
lowing staining, cells were washed with PBS, fixed in PBS containing 2% 
paraformaldehyde, and analyzed on a FACSCalibur (BD Biosciences). Data 
were acquired by CellQuest software (BD Biosciences) and analyzed by 
FlowJo software (Tree Star Inc.).
Cytokine production analysis. Peritoneal resident cells from C57BL/6 and 
IL-1R–/– mice were harvested by lavage. Cells were washed once with HCM 
and resuspended in HCM at a density of 3 × 106/ml, and 0.5 ml of the cell 
suspension was plated into a 24-well plate. Cells were treated with MSU 
crystals (0.5 mg/ml) or left untreated. At 16 hours after treatment, IL-1b 
and TNF-a concentrations in the culture medium were determined by 
ELISA according to the manufacturer’s instructions (R&D Systems). KC, 
MIP-2, IL-1b, and TNF-a concentrations in the peritoneal lavage fluids 
were also determined by ELISA (R&D Systems).
Statistics. Statistical analysis in each independent experiment was per-
formed with an unpaired, 2-tailed Student’s t test. For the experiments 
shown in Figure 2 that were repeated 3 times, data were combined and 
analyzed using a linear mixed model (60), with experiment as the random 
effect. Data in Figure 2 were also analyzed by analysis of variance for mixed 
models (ANOVAMM) using restricted estimation by maximum likelihood 
(REML) (61, 62) and by pairwise comparisons between WT and TLR-defi-
cient mice by Tukey’s honest significant difference using the estimated 
nondiagonal covariance structure. The distributional characteristics of 
model residuals were evaluated for normality both graphically by visual 
inspection of frequency histograms and by the Kolmogorov-Smirnov good-
ness-of-fit test for normality. The latter analyses were performed using the 
SAS Proc Mixed statistical program (SAS Institute Inc.). Both analyses of 
the data in Figure 2 generated concordant results. Data are reported as 
mean ± SEM. P < 0.05 was considered statistically significant.
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